Sanofi Aventis US, 1041 Route 202-206 N, Bridgewater, NJ 08807-0800, United States.
Bioorg Med Chem Lett. 2011 Jan 1;21(1):66-75. doi: 10.1016/j.bmcl.2010.11.071. Epub 2010 Nov 21.
A Comparative Molecular Similarity Indices Analysis (CoMSIA) was performed for 2,6-substituted-4-monosubstituted aminopyrimidine antagonists of prostaglandin D(2) receptor (DP). Both two-component (Q(2) = 0.63, R(2) = 0.82, SEE = 0.47 pIC(50)) and three-component (Q(2) = 0.70, R(2) = 0.91, SEE = 0.36 pIC(50)) CoMSIA models were established. Two hydrogen-bond acceptors with spatial separation of about 8Å are shown as optimal for binding. A large hydrophobic center that separates the two acceptors confers to the potency of the 2,6-substituted-4-monosubstituted aminopyrimidine. The models were used to predict IC(50) values for compounds which had functional groups different from those in the training set.
进行了 2,6-取代-4-单取代氨基嘧啶类前列腺素 D2 受体(DP)拮抗剂的比较分子相似性指数分析(CoMSIA)。建立了两个双组份(Q(2) = 0.63,R(2) = 0.82,SEE = 0.47 pIC(50))和三个双组份(Q(2) = 0.70,R(2) = 0.91,SEE = 0.36 pIC(50))CoMSIA 模型。结果表明,大约 8Å 的空间分离的两个氢键受体是最佳结合方式。两个受体之间的大疏水区赋予了 2,6-取代-4-单取代氨基嘧啶的活性。该模型用于预测具有与训练集中不同官能团的化合物的 IC(50)值。